Medicare IHC Claims With Melanoma Dxs Increased, Study Finds

With sparse guidance regarding best practices for IHC in melanoma diagnosis, more research is needed to optimize use of IHC in this setting, according to the authors.

Related Keywords

New York University , New York , United States , California , Kentucky , Los Angeles , Colorado , Louisiana , New Mexico , Kenechukwu Ojukwu , Alexandra Flamm , National Cancer Institute , University Of California , American Society Of Dermatopathology , Department Of Pathology , California Department Of Public Health , National Clinician Scholars Program , York University , University Of Colorado , End Results , San Jose Monterey , New York City , American Society , Whitney High , California Department , Public Health , Melanoma , Malignant Melanoma , Skin Cancer , Alignant Skin Neoplasm , Dermatopathology , Immunohistochemistry , Medicare , Biologic Therapy , Iologics , Cancer , Alignant Neoplasia , Arcinoma , Alignant Neoplasm , Clinical Guidelines , Guidelines , Cutaneous Melanoma , Epidemiology , Grant , Jobs , Career , Profession , Employment , Job Interview , Job Contract , Employment Contract ,